Skip to main content
. 2020 Jul 20;180(9):1–9. doi: 10.1001/jamainternmed.2020.2821

Table 3. Adverse Events.

Adverse event No. of participants (%) P valuea
Placebo (n = 180) Meloxicam (n = 184)
Organ system affected
Gastrointestinal 6 (3) 12 (7) .23
Renal 0 1 (1) >.99
Liver 0 0
Cardiovascular 4 (2) 1 (1) .21
Other 15 (8) 13 (7) .70
Serious adverse event 3 (2) 4 (2) >.99
a

Obtained from Fisher exact test.